Once known best for its toxic effects, recent work has shown that hydrogen sulfide (H<sub>2</sub> S) has many roles as a cellular messenger. For example, both endogenously produced and exogenously supplied H<sub>2</sub> S protect against cellular damage and death associated with ischemia/reperfusion injury in mammals. The mechanistic relationship between beneficial and toxic effects of H<sub>2</sub> S is not understood. We have developed C. elegans as a model to understand the mechanistic basis of H<sub>2</sub> S effects in animals. In addition to facile genetic and genomic tools, using C. elegans provides the ability to precisely control both genotype and cellular H<sub>2</sub> S exposure. C. elegans grown in 50 ppm H<sub>2</sub> S are long-lived and resistant to hypoxia-induced disruption of protein homeostasis. The early transcriptional response to H<sub>2</sub> S requires the C. elegans orthologue of the hypoxia-inducible transcription factor,
hif-1. HIF-1 promotes survival in H<sub>2</sub> S, at least in part, by upregulating expression of
sqrd-1, which encodes the sulfide-quinone oxidoreductase. SQRD-1 catalyzes the first step in the mitochondrial oxidation of H<sub>2</sub> S. In an unbiased forward genetic screen, we found that expression of
rhy-1 suppresses lethality of
hif-1 mutant animals in 50 ppm H<sub>2</sub> S. RHY-1 is an integral-membrane ER protein with predicted acyltransferase (ACYL3) activity. The ACYL3 family is large and conserved across species from bacteria to primates, but the function of these enzymes is largely unstudied. RHY-1 was first characterized as a negative regulator of HIF-1, and our data indicate that it also promotes survival in H<sub>2</sub> S independently of HIF-1. To understand RHY-1 function we have used biotinylation by antibody recognition (BAR) to identify proteins that interact with RHY-1. We show that RHY-1 directly associates with CYSL proteins, which are orthologues of cystathionine -synthase. Mutations in
cysl-1 abrogate RHY-1 function to regulate HIF-1 and to promote survival independently of HIF-1. We have also identified a novel methyltransferase, RIPS-1, that is required for RHY-1 to promote survival in H<sub>2</sub> S but which is dispensable for the proper regulation of HIF-1. Together, our data show that RHY-1 promotes survival in H<sub>2</sub> S through a novel mechanism which can bypass the only known catabolic pathway for H<sub>2</sub> S in vivo. Understanding the mechanism of RHY-1 activity in H<sub>2</sub> S will begin to elucidate the relationship between H<sub>2</sub> S signaling and toxicity, and could lead to new therapeutic strategies to modulate endogenous H<sub>2</sub> S levels.